Arsanis, Inc. (92) | Uncategorized (7)
Recent Contracts
-
Form of Pre-Funded
(Filed With SEC on March 3, 2022)
-
Third Amendment to Option Agreement, dated July 15, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
(Filed With SEC on July 15, 2021)
-
Second Amendment to Option Agreement, dated June 7, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
(Filed With SEC on June 7, 2021)
-
First Amendment to Option Agreement dated May 3, 2021, by and between X4 Pharmaceuticals Inc. and Abingworth Bioventures 8 LP
(Filed With SEC on May 6, 2021)
-
Description of Registered Securities
(Filed With SEC on March 19, 2021)
-
Option Agreement, dated March 18, 2021, by and between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
(Filed With SEC on March 19, 2021)
-
Description of Registered Securities
(Filed With SEC on March 12, 2020)
